4//SEC Filing
Simon, Christopher 4
Accession 0001127602-23-019619
CIK 0000313143other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:17 PM ET
Size
8.8 KB
Accession
0001127602-23-019619
Insider Transaction Report
Form 4
Simon, Christopher
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2023-06-29$28.61/sh+196,746$5,629,887→ 414,113 total - Tax Payment
Common Stock
2023-06-29$84.84/sh−117,667$9,982,868→ 296,446 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2023-06-29−196,746→ 0 totalExercise: $28.61From: 2017-06-29Exp: 2023-06-29→ Common Stock (196,746 underlying)
Footnotes (4)
- [F1]Represents an automatic exercise of options granted in 2016 and scheduled to expire after June 29, 2023, as reflected in this Form 4.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001674993
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:17 PM ET
- Size
- 8.8 KB